Koch Family Medicine
Morton, Illinois, United States
Family practice physician in Morton, Illinois
411 Maxine Dr, Morton, IL 61550
About Koch Family Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Koch Family Medicine
During the past decade, Koch Family Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on
average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1999-01-04
2007-03-31
Completed
350
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
2001-05-01
Completed
608
A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
2000-09-01
Completed
36
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
2002-05-01
2010-09-01
Completed
195
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
2002-11-14
2022-12-31
Completed
413
Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
2003-01-01
Completed
328
A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)
2003-04-01
Withdrawn
300
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Koch Family Medicine" #1 sponsor was "Kowa Research Institute, Inc." with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "LumiraDx UK Limited" with 1 trials sponsored and "Revive Therapeutics, Ltd."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Koch Family Medicine
According to Clinical.Site data, the most researched conditions in "Koch Family Medicine" are
"Severe Hypertriglyceridemia" (2 trials), "Atrial Fibrillation" (1 trials), "COVID-19" (1 trials), "Covid19" (1 trials) and "Influenza A" (1 trials). Many other conditions were trialed in "Koch Family Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Koch Family Medicine
Most popular intervention types in "Koch Family Medicine" are "Drug" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials), "Bucillamine" (1 trials) and "LumiraDx SARS-CoV-2 & Flu A/B test" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Koch Family Medicine
The vast majority of trials in "Koch Family Medicine" are
7 trials for "All" genders.
Clinical Trials Status at Koch Family Medicine
Currently, there are NaN active trials in "Koch Family Medicine".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 3 completed trials in Koch Family Medicine,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Koch Family Medicine, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".